| pubmed-article:12891528 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12891528 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12891528 | lifeskim:mentions | umls-concept:C0021390 | lld:lifeskim |
| pubmed-article:12891528 | lifeskim:mentions | umls-concept:C0160390 | lld:lifeskim |
| pubmed-article:12891528 | lifeskim:mentions | umls-concept:C0039902 | lld:lifeskim |
| pubmed-article:12891528 | lifeskim:mentions | umls-concept:C1524003 | lld:lifeskim |
| pubmed-article:12891528 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:12891528 | pubmed:dateCreated | 2003-7-31 | lld:pubmed |
| pubmed-article:12891528 | pubmed:abstractText | Thioguanine (6-TG) has been studied as an alternative thiopurine in inflammatory bowel disease (IBD). Short-term safety and efficacy data were favorable. Experience with 6-TG in patients with acute lymphoblastic leukemia raised long-term safety concerns when implicated in nodular regenerative hyperplasia (NRH) of the liver and portal hypertension. The aim of this study was to describe the association between 6-TG and NRH in IBD. | lld:pubmed |
| pubmed-article:12891528 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12891528 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12891528 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12891528 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12891528 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12891528 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12891528 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:12891528 | pubmed:issn | 0016-5085 | lld:pubmed |
| pubmed-article:12891528 | pubmed:author | pubmed-author:BCC | lld:pubmed |
| pubmed-article:12891528 | pubmed:author | pubmed-author:MartinPaulP | lld:pubmed |
| pubmed-article:12891528 | pubmed:author | pubmed-author:DubinskyMarla... | lld:pubmed |
| pubmed-article:12891528 | pubmed:author | pubmed-author:AbreuMaria... | lld:pubmed |
| pubmed-article:12891528 | pubmed:author | pubmed-author:TarganStephan... | lld:pubmed |
| pubmed-article:12891528 | pubmed:author | pubmed-author:VasiliauskasE... | lld:pubmed |
| pubmed-article:12891528 | pubmed:author | pubmed-author:PoordadFred... | lld:pubmed |
| pubmed-article:12891528 | pubmed:author | pubmed-author:GellerStephen... | lld:pubmed |
| pubmed-article:12891528 | pubmed:author | pubmed-author:VierlingJohn... | lld:pubmed |
| pubmed-article:12891528 | pubmed:author | pubmed-author:SinghHardeepH | lld:pubmed |
| pubmed-article:12891528 | pubmed:author | pubmed-author:PapadakisKost... | lld:pubmed |
| pubmed-article:12891528 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12891528 | pubmed:volume | 125 | lld:pubmed |
| pubmed-article:12891528 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12891528 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12891528 | pubmed:pagination | 298-303 | lld:pubmed |
| pubmed-article:12891528 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:12891528 | pubmed:meshHeading | pubmed-meshheading:12891528... | lld:pubmed |
| pubmed-article:12891528 | pubmed:meshHeading | pubmed-meshheading:12891528... | lld:pubmed |
| pubmed-article:12891528 | pubmed:meshHeading | pubmed-meshheading:12891528... | lld:pubmed |
| pubmed-article:12891528 | pubmed:meshHeading | pubmed-meshheading:12891528... | lld:pubmed |
| pubmed-article:12891528 | pubmed:meshHeading | pubmed-meshheading:12891528... | lld:pubmed |
| pubmed-article:12891528 | pubmed:meshHeading | pubmed-meshheading:12891528... | lld:pubmed |
| pubmed-article:12891528 | pubmed:meshHeading | pubmed-meshheading:12891528... | lld:pubmed |
| pubmed-article:12891528 | pubmed:meshHeading | pubmed-meshheading:12891528... | lld:pubmed |
| pubmed-article:12891528 | pubmed:meshHeading | pubmed-meshheading:12891528... | lld:pubmed |
| pubmed-article:12891528 | pubmed:meshHeading | pubmed-meshheading:12891528... | lld:pubmed |
| pubmed-article:12891528 | pubmed:meshHeading | pubmed-meshheading:12891528... | lld:pubmed |
| pubmed-article:12891528 | pubmed:meshHeading | pubmed-meshheading:12891528... | lld:pubmed |
| pubmed-article:12891528 | pubmed:meshHeading | pubmed-meshheading:12891528... | lld:pubmed |
| pubmed-article:12891528 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12891528 | pubmed:articleTitle | 6-thioguanine can cause serious liver injury in inflammatory bowel disease patients. | lld:pubmed |
| pubmed-article:12891528 | pubmed:affiliation | Pediatric Inflammatory Bowel Disease Center, Cedars-Sinai Medical Center, 8635 West Third Street, Suite 1165W, Los Angeles, California 90048, USA. dubinskym@csmc.edu | lld:pubmed |
| pubmed-article:12891528 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12891528 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12891528 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12891528 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12891528 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12891528 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12891528 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12891528 | lld:pubmed |
